| Study title |
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR) |
| Disease or condition |
Ulcerative colitis |
| Study type |
Interventional (Clinical Trial) |
| Intervention/treatment |
Guselkumab or Ustekinumab or Placebo |
| Phase |
2b/3 |
| Study site |
University of North Carolina |
| Study location |
Chapel Hill |
| Principal investigator |
Animesh Jain ibdtrials@med.unc.edu |
| Study coordinator |
Emily English emily_english@med.unc.edu |
| Phone contact |
919-843-8105 |
| Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04033445 |
